SELECT MEDICAL HOLDINGS CORP·4

Jul 1, 2:16 PM ET

Saich John A. 4

4 · SELECT MEDICAL HOLDINGS CORP · Filed Jul 1, 2026

Research Summary

AI-generated summary of this filing

Updated

Select Medical (SEM) President John Saich Transfers 736,412 Shares

What Happened

  • John A. Saich, President of Select Medical Holdings Corp (SEM), disposed of 736,412 shares on 2026-06-30. The filing reports the disposition at $0.00 per share (total proceeds $0) because the shares were transferred under the Agreement and Plan of Merger and converted into interests of the acquiring parent.

Key Details

  • Transaction date: 2026-06-30; Transaction code: J (other acquisition or disposition).
  • Shares reported disposed: 736,412 (519,745 common shares + 216,667 restricted shares, per footnote).
  • Price: $0.00 per share; Total proceeds reported: $0.
  • Shares owned after transaction: not specified in the provided Form 4.
  • Footnotes: F1 — disposition occurred under the Merger Agreement (Stallion/Parent) dated March 2, 2026. F2 — immediately prior to the merger effective time, Mr. Saich contributed the listed common and restricted shares to Parent and received equivalent Parent common/restricted shares, which were then exchanged for interests in Stallion Group Parent, LP.
  • Filing date: 2026-07-01; the Form 4 covers the period ending 2026-06-30 (no late-filing indication in the provided data).

Context

  • This was not an open-market sale but a transfer as part of a corporate merger/transaction; the $0 proceeds reflect an equity conversion rather than a cash sale. Such merger-related dispositions change holdings in the issuer but typically reflect deal mechanics rather than a direct signal of the insider’s view on the public equity price.

Insider Transaction Report

Form 4Exit
Period: 2026-06-30
Saich John A.
PRESIDENT
Transactions
  • Other

    Common Stock

    [F1][F2]
    2026-06-30736,4120 total
Footnotes (2)
  • [F1]This Form 4 reports securities disposed of under the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation ("Parent"), and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026).
  • [F2]Immediately prior to the effective time of the merger, the Reporting Person contributed 519,745 common shares and 216,667 restricted shares to Parent in exchange for an equivalent amount of shares of common stock ("Parent Common Shares") and restricted shares, respectively, of Parent, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP.
Signature
/s/ John F. Duggan, Attorney-in-Fact|2026-07-01

Documents

2 files